breast cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1). Age= 18 years old. (2). Histological confirmation of breast cancer and surgery can not remove all metastatic lesions. (3). After comprehensive treatment, routine imaging examination achieves significant relief, which meets one of the following two items: The image is completely mitigated; CT or MRI shows that the tumor lesion is persistently stable, has received radiotherapy, or has been stable for at least 6 months. (4). Subject has paraffin embedded tumor tissue within two years. (5). Subject agrees to participate in the study and has signed an informed consent form. (6). Be able to follow the study protocol and follow-up process.
Exclusion criteria
Exclusion criteria: (1). Patients diagnosed with any malignant tumor within the past 5 years; (2). Suffering from other serious systemic diseases at the same time, which the investigator believes may interfere with the treatment, evaluation and compliance of this trial, including severe respiratory, circulatory, nervous, mental, digestive, endocrine, immune, urinary and other systemic diseases; (3). The investigator judges that the patient is not suitable to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Molecular residue detection; | — |
Secondary
| Measure | Time frame |
|---|---|
| immune index; | — |
Countries
China
Contacts
Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School